Delivery Order SPE2DB20D3101-SPE2DB23FRPM2
Award Date
6/15/23
Potential Completion Date
6/16/23
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,912.60 firm fixed-price delivery order is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical medication used in the management of diabetes. The contract has an ultimate completion date of July 12, 2022 and was awarded on July 11, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,159.08 firm fixed-price delivery order is for the supply of Insulin Lispro 100 Unit/mL, a critical medication used to manage diabetes. The award does not have a set-aside designation, indicating open competition. The contract is a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,323.66 delivery order is for Insulin Lispro 100 Unit/mL Pen 3mL, a pharmaceutical product used for diabetes management. The contract has a ceiling value of $1,323.66 and is a firm fixed-price delivery order, with a completion date of July 25, 2023. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,057.47 delivery order is for the supply of insulin lispro 100 unit/mL pens, a critical medication for diabetes management. The contract has a firm fixed price and runs until September 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Insulin Lispro 100 Unit/mL vials, a pharmaceutical product used for the management of diabetes. The contract was awarded on August 9, 2021, with a ceiling value of $2,283.98 and a completion date of August 10, 2021. The contract is a Delivery Order, with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,239.54 for the supply of Insulin Lispro 100 Unit/mL Vials (10 mL). The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, with a performance location in Conshohocken, PA. The contract is a Firm Fixed Price arrangement with a completion date of May 24, 2022. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $1,048.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Insulin Lispro 100 Unit/mL Pens, a critical medication for diabetes management. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.24 delivery order contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical medication for diabetes management. The contract has an ultimate completion date of October 24, 2022 and is a firm fixed-price delivery order. This award is associated with AmerisourceBergen's larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Lispro 100 Unit/mL Pen 3mL. The $1,094.10 fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range...
This federal contract award, with ID SPE2DB20D3101|SPE2DB22FJ1H1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,343.28 firm-fixed-price delivery order is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical diabetes medication. The award is not designated as a set-aside contract. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...